The gout therapeutics market was valued at USD 3.13 billion in 2024 and is projected to grow at a CAGR of 7.0% from 2025 to 2034. The market is estimated at USD 3.34 billion in 2025 and is expected to reach USD 6.15 billion by 2034. Gout is a form of inflammatory arthritis caused by uric acid crystal deposition. The market comprises urate-lowering therapies, anti-inflammatories, and novel...
